# Huanghou Zhixie Diwan in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)

> **NCT07721012** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Lei Yunshang Group** · enrollment: 120 (estimated)

## Conditions studied

- Patients With Irritable Bowel Syndrome With Diarrhea

## Interventions

- **DRUG:** Huanghou Zhixie Diwan group
- **DRUG:** Huanghou Zhixie Diwan mimic

## Key facts

- **NCT ID:** NCT07721012
- **Lead sponsor:** Lei Yunshang Group
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-07-31
- **Primary completion:** 2027-08-31
- **Final completion:** 2027-08-31
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-07-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07721012

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07721012, "Huanghou Zhixie Diwan in the Treatment of Irritable Bowel Syndrome With Diarrhea (IBS-D)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07721012. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*